National Health Investors, Inc. (NYSE:NHI) Receives Consensus Recommendation of "Moderate Buy" from Analysts
National Health Investors, Inc. (NYSE:NHI) has received a "Moderate Buy" consensus recommendation from eight brokerages, with an average 12-month price target of $83.86, significantly higher than its current share price of $71.23. The company also reported strong quarterly earnings of $1.19 EPS on $121.32 …